American Century Companies Inc Omega Therapeutics, Inc. Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$1.86 - $3.2 $13,516 - $23,254	-7,267 Reduced 28.71%	18,048 $37,000
Q1 2024 May 14, 2024	BUY	$2.73 - $5.32 $35,735 - $69,638	13,090 Added 107.08%	25,315 $92,000
Q4 2023 Feb 13, 2024	BUY	$1.35 - $3.21 $16,503 - $39,242	12,225 New	12,225 $36,000
Q3 2023 Nov 13, 2023	BUY	$2.15 - $5.68 $26,283 - $69,438	12,225 New	12,225 $26,000

43.3M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $6.22M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.